{"id":"https://openalex.org/W3127048941","doi":"https://doi.org/10.1021/acs.jmedchem.0c01886","title":"Movement to the Clinic of Soluble Epoxide Hydrolase Inhibitor EC5026 as an Analgesic for Neuropathic Pain and for Use as a Nonaddictive Opioid Alternative","display_name":"Movement to the Clinic of Soluble Epoxide Hydrolase Inhibitor EC5026 as an Analgesic for Neuropathic Pain and for Use as a Nonaddictive Opioid Alternative","alternate_titles":[],"publication_year":2021,"publication_date":"2021-02-07","ids":{"openalex":"https://openalex.org/W3127048941","doi":"https://doi.org/10.1021/acs.jmedchem.0c01886","mag":"3127048941","pmid":"https://pubmed.ncbi.nlm.nih.gov/33550801","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/7917437"},"language":"en","primary_location":{"id":"doi:10.1021/acs.jmedchem.0c01886","doi":"https://doi.org/10.1021/acs.jmedchem.0c01886","is_oa":true,"landing_page_url":"https://doi.org/10.1021/acs.jmedchem.0c01886","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W3127048941"],"child_works_count":2,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1021/acs.jmedchem.0c01886","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5026538320","display_name":"Bruce D. Hammock","orcid":"https://orcid.org/0000-0003-1408-8317","observed_orcids":["https://orcid.org/0000-0003-1408-8317"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Bruce D. Hammock","raw_affiliation_strings":["EicOsis Human Health Inc., Subsidiary of EicOsis LLC, 1930 Fifth Street, Suite A, Davis, California 95616, United States"],"raw_orcid":"https://orcid.org/0000-0003-1408-8317","affiliations":[{"raw_affiliation_string":"EicOsis Human Health Inc., Subsidiary of EicOsis LLC, 1930 Fifth Street, Suite A, Davis, California 95616, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031532167","display_name":"Cindy B. McReynolds","orcid":"https://orcid.org/0000-0003-3309-1773","observed_orcids":["https://orcid.org/0000-0003-3309-1773"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Cindy B. McReynolds","raw_affiliation_strings":["EicOsis Human Health Inc., Subsidiary of EicOsis LLC, 1930 Fifth Street, Suite A, Davis, California 95616, United States"],"raw_orcid":"https://orcid.org/0000-0003-3309-1773","affiliations":[{"raw_affiliation_string":"EicOsis Human Health Inc., Subsidiary of EicOsis LLC, 1930 Fifth Street, Suite A, Davis, California 95616, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Karen Wagner","orcid":"https://orcid.org/0000-0002-5238-7847","observed_orcids":["https://orcid.org/0000-0002-5238-7847"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Karen Wagner","raw_affiliation_strings":["EicOsis Human Health Inc., Subsidiary of EicOsis LLC, 1930 Fifth Street, Suite A, Davis, California 95616, United States"],"raw_orcid":"https://orcid.org/0000-0002-5238-7847","affiliations":[{"raw_affiliation_string":"EicOsis Human Health Inc., Subsidiary of EicOsis LLC, 1930 Fifth Street, Suite A, Davis, California 95616, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002973968","display_name":"Alan R. Buckpitt","orcid":"https://orcid.org/0000-0001-6643-5208","observed_orcids":["https://orcid.org/0000-0001-6643-5208"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alan Buckpitt","raw_affiliation_strings":["EicOsis Human Health Inc., Subsidiary of EicOsis LLC, 1930 Fifth Street, Suite A, Davis, California 95616, United States"],"raw_orcid":"https://orcid.org/0000-0001-6643-5208","affiliations":[{"raw_affiliation_string":"EicOsis Human Health Inc., Subsidiary of EicOsis LLC, 1930 Fifth Street, Suite A, Davis, California 95616, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055356324","display_name":"Irene Cort\u00e9s\u2010Puch","orcid":"https://orcid.org/0000-0002-3639-5046","observed_orcids":["https://orcid.org/0000-0002-3639-5046"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Irene Cortes-Puch","raw_affiliation_strings":["EicOsis Human Health Inc., Subsidiary of EicOsis LLC, 1930 Fifth Street, Suite A, Davis, California 95616, United States"],"raw_orcid":"https://orcid.org/0000-0002-3639-5046","affiliations":[{"raw_affiliation_string":"EicOsis Human Health Inc., Subsidiary of EicOsis LLC, 1930 Fifth Street, Suite A, Davis, California 95616, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071579078","display_name":"Glenn E Croston","orcid":"https://orcid.org/0000-0002-6352-0922","observed_orcids":["https://orcid.org/0000-0002-6352-0922"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Glenn Croston","raw_affiliation_strings":["EicOsis Human Health Inc., Subsidiary of EicOsis LLC, 1930 Fifth Street, Suite A, Davis, California 95616, United States"],"raw_orcid":"https://orcid.org/0000-0002-6352-0922","affiliations":[{"raw_affiliation_string":"EicOsis Human Health Inc., Subsidiary of EicOsis LLC, 1930 Fifth Street, Suite A, Davis, California 95616, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064274524","display_name":"Kin Sing Stephen Lee","orcid":"https://orcid.org/0000-0003-4541-3063","observed_orcids":["https://orcid.org/0000-0003-4541-3063"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kin Sing Stephen Lee","raw_affiliation_strings":["Synthia LLC, P.O. Box 1238, Gualala, California 95445, United States"],"raw_orcid":"https://orcid.org/0000-0003-4541-3063","affiliations":[{"raw_affiliation_string":"Synthia LLC, P.O. Box 1238, Gualala, California 95445, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000512905","display_name":"Jun Yang","orcid":"https://orcid.org/0000-0001-8126-1728","observed_orcids":["https://orcid.org/0000-0001-8126-1728"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jun Yang","raw_affiliation_strings":["EicOsis Human Health Inc., Subsidiary of EicOsis LLC, 1930 Fifth Street, Suite A, Davis, California 95616, United States"],"raw_orcid":"https://orcid.org/0000-0001-8126-1728","affiliations":[{"raw_affiliation_string":"EicOsis Human Health Inc., Subsidiary of EicOsis LLC, 1930 Fifth Street, Suite A, Davis, California 95616, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"William K. Schmidt","orcid":"https://orcid.org/0000-0001-5841-4810","observed_orcids":["https://orcid.org/0000-0001-5841-4810"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"William K. Schmidt","raw_affiliation_strings":["EicOsis Human Health Inc., Subsidiary of EicOsis LLC, 1930 Fifth Street, Suite A, Davis, California 95616, United States"],"raw_orcid":"https://orcid.org/0000-0001-5841-4810","affiliations":[{"raw_affiliation_string":"EicOsis Human Health Inc., Subsidiary of EicOsis LLC, 1930 Fifth Street, Suite A, Davis, California 95616, United States","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5066735935","display_name":"Sung Hee Hwang","orcid":"https://orcid.org/0000-0002-9891-928X","observed_orcids":["https://orcid.org/0000-0002-9891-928X"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Sung Hee Hwang","raw_affiliation_strings":["EicOsis Human Health Inc., Subsidiary of EicOsis LLC, 1930 Fifth Street, Suite A, Davis, California 95616, United States"],"raw_orcid":"https://orcid.org/0000-0002-9891-928X","affiliations":[{"raw_affiliation_string":"EicOsis Human Health Inc., Subsidiary of EicOsis LLC, 1930 Fifth Street, Suite A, Davis, California 95616, United States","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5066735935"],"corresponding_institution_ids":[],"apc_list":{"value":5000,"currency":"USD","value_usd":5000},"apc_paid":{"value":5000,"currency":"USD","value_usd":5000},"fwci":9.5165,"has_fulltext":true,"cited_by_count":177,"citation_normalized_percentile":{"value":0.99522203,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":100},"biblio":{"volume":"64","issue":"4","first_page":"1856","last_page":"1872"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12910","display_name":"Eicosanoids and Hypertension Pharmacology","score":0.98580002784729,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12910","display_name":"Eicosanoids and Hypertension Pharmacology","score":0.98580002784729,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10196","display_name":"Pain Mechanisms and Treatments","score":0.0031999999191612005,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":0.0015999999595806003,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/soluble-epoxide-hydrolase-inhibition","display_name":"soluble epoxide hydrolase inhibition","score":0.9160000085830688},{"id":"https://openalex.org/keywords/neuropathic-pain","display_name":"neuropathic pain","score":0.9459999799728394},{"id":"https://openalex.org/keywords/arachidonic-acid-metabolism","display_name":"arachidonic acid metabolism","score":0.8600000143051147},{"id":"https://openalex.org/keywords/cytochrome-p450","display_name":"cytochrome P450","score":0.7390000224113464},{"id":"https://openalex.org/keywords/endoplasmic-reticulum-stress","display_name":"endoplasmic reticulum stress","score":0.8659999966621399},{"id":"https://openalex.org/keywords/cellular-senescence","display_name":"cellular senescence","score":0.9769999980926514},{"id":"https://openalex.org/keywords/resolution-of-inflammation","display_name":"inflammation resolution","score":0.9509999752044678},{"id":"https://openalex.org/keywords/blood-pressure-regulation","display_name":"blood pressure regulation","score":0.5540000200271606},{"id":"https://openalex.org/keywords/transition-state-mimics","display_name":"transition state mimics","score":0.6460000276565552}],"concepts":[{"id":"https://openalex.org/C18605011","wikidata":"https://www.wikidata.org/wiki/Q17916975","display_name":"Epoxide hydrolase 2","level":3,"score":0.8075271844863892},{"id":"https://openalex.org/C2780820201","wikidata":"https://www.wikidata.org/wiki/Q173235","display_name":"Analgesic","level":2,"score":0.7635514736175537},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.7512243986129761},{"id":"https://openalex.org/C2776914184","wikidata":"https://www.wikidata.org/wiki/Q101991","display_name":"Inflammation","level":2,"score":0.6684044003486633},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6236327290534973},{"id":"https://openalex.org/C101819947","wikidata":"https://www.wikidata.org/wiki/Q87444516","display_name":"Epoxide hydrolase","level":4,"score":0.615910530090332},{"id":"https://openalex.org/C2777107010","wikidata":"https://www.wikidata.org/wiki/Q2798704","display_name":"Neuropathic pain","level":2,"score":0.5202202200889587},{"id":"https://openalex.org/C2781063702","wikidata":"https://www.wikidata.org/wiki/Q427523","display_name":"Opioid","level":3,"score":0.4443742632865906},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.2701231837272644},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.1792372763156891},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.1737688183784485},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.1403276026248932},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.12325477600097656},{"id":"https://openalex.org/C87644729","wikidata":"https://www.wikidata.org/wiki/Q547502","display_name":"Microsome","level":3,"score":0.1100253164768219}],"mesh":[{"descriptor_ui":"D000700","descriptor_name":"Analgesics","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000700","descriptor_name":"Analgesics","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004285","descriptor_name":"Dogs","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D004851","descriptor_name":"Epoxide Hydrolases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D006736","descriptor_name":"Horses","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007249","descriptor_name":"Inflammation","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009437","descriptor_name":"Neuralgia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D010671","descriptor_name":"Phenylurea Compounds","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D010671","descriptor_name":"Phenylurea Compounds","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D013329","descriptor_name":"Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015394","descriptor_name":"Molecular Structure","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017207","descriptor_name":"Rats, Sprague-Dawley","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017321","descriptor_name":"Clinical Trials, Phase I as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D059865","descriptor_name":"Endoplasmic Reticulum Stress","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1021/acs.jmedchem.0c01886","doi":"https://doi.org/10.1021/acs.jmedchem.0c01886","is_oa":true,"landing_page_url":"https://doi.org/10.1021/acs.jmedchem.0c01886","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:7917437","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC7917437/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC7917437/pdf/","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"J Med Chem","raw_type":"Text"},{"id":"pmid:33550801","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/33550801","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of medicinal chemistry","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1021/acs.jmedchem.0c01886","doi":"https://doi.org/10.1021/acs.jmedchem.0c01886","is_oa":true,"landing_page_url":"https://doi.org/10.1021/acs.jmedchem.0c01886","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G21403879","display_name":"Inhibiting soluble epoxide hydrolase as a treatment for chemotherapy inducedperipheral neuropathic pain","funder_award_id":"R43CA233371","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G3324154467","display_name":"sEH Inhibitors to Treat Neuropathic Pain","funder_award_id":"R43ES025598","funder_id":"https://openalex.org/F4320337361","funder_display_name":"National Institute of Environmental Health Sciences"},{"id":"https://openalex.org/G3474668483","display_name":null,"funder_award_id":"R43/R44 ES025598","funder_id":"https://openalex.org/F4320337361","funder_display_name":"National Institute of Environmental Health Sciences"},{"id":"https://openalex.org/G4383194787","display_name":null,"funder_award_id":"UG3/UH3NS094258","funder_id":"https://openalex.org/F4320337359","funder_display_name":"National Institute of Neurological Disorders and Stroke"},{"id":"https://openalex.org/G7950325597","display_name":"Development of a Soluble Epoxide Hydrolase Inhibitor to Spare or Replace Opioid Analgesics","funder_award_id":"UG3DA048767","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"},{"id":"https://openalex.org/G851699235","display_name":"Development of an Oral Analgesic for Neuropathic Pain","funder_award_id":"UH3NS094258","funder_id":"https://openalex.org/F4320337359","funder_display_name":"National Institute of Neurological Disorders and Stroke"},{"id":"https://openalex.org/G8550676706","display_name":"sEH Inhibitors to Treat Neuropathic Pain","funder_award_id":"R44ES025598","funder_id":"https://openalex.org/F4320337361","funder_display_name":"National Institute of Environmental Health Sciences"}],"funders":[{"id":"https://openalex.org/F4320337347","display_name":"National Institute on Drug Abuse","ror":"https://ror.org/00fq5cm18"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"},{"id":"https://openalex.org/F4320337359","display_name":"National Institute of Neurological Disorders and Stroke","ror":"https://ror.org/01s5ya894"},{"id":"https://openalex.org/F4320337361","display_name":"National Institute of Environmental Health Sciences","ror":"https://ror.org/00j4k1h63"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3127048941.pdf","grobid_xml":"https://content.openalex.org/works/W3127048941.grobid-xml"},"referenced_works_count":56,"referenced_works":["https://openalex.org/W201943430","https://openalex.org/W1512284860","https://openalex.org/W1595102411","https://openalex.org/W1964718302","https://openalex.org/W1972546856","https://openalex.org/W1980670563","https://openalex.org/W1981594250","https://openalex.org/W1984937298","https://openalex.org/W1986824214","https://openalex.org/W1989552333","https://openalex.org/W1992781228","https://openalex.org/W1993788673","https://openalex.org/W1995454938","https://openalex.org/W1997036567","https://openalex.org/W1999138233","https://openalex.org/W2006634108","https://openalex.org/W2015296161","https://openalex.org/W2036288371","https://openalex.org/W2047786869","https://openalex.org/W2071253818","https://openalex.org/W2097927167","https://openalex.org/W2098811278","https://openalex.org/W2111204258","https://openalex.org/W2115197899","https://openalex.org/W2117356638","https://openalex.org/W2121802937","https://openalex.org/W2129077714","https://openalex.org/W2129416038","https://openalex.org/W2133280611","https://openalex.org/W2135130257","https://openalex.org/W2135910194","https://openalex.org/W2140116636","https://openalex.org/W2142310620","https://openalex.org/W2147605027","https://openalex.org/W2147645926","https://openalex.org/W2160308798","https://openalex.org/W2162233719","https://openalex.org/W2162894871","https://openalex.org/W2187828640","https://openalex.org/W2327787157","https://openalex.org/W2471713672","https://openalex.org/W2545300118","https://openalex.org/W2615216250","https://openalex.org/W2723007231","https://openalex.org/W2943846858","https://openalex.org/W2947995747","https://openalex.org/W2949645446","https://openalex.org/W2972051445","https://openalex.org/W3014761768","https://openalex.org/W3015359961","https://openalex.org/W3038469683","https://openalex.org/W3040039498","https://openalex.org/W3044475179","https://openalex.org/W3081905990","https://openalex.org/W3082844690","https://openalex.org/W3112030344"],"related_works":["https://openalex.org/W2395325846","https://openalex.org/W1981594250","https://openalex.org/W192295082","https://openalex.org/W2723007231","https://openalex.org/W3177283763","https://openalex.org/W4389033954","https://openalex.org/W3120874051","https://openalex.org/W3200368004","https://openalex.org/W1126565480","https://openalex.org/W4401926625"],"abstract_inverted_index":{"High":[0],"Resolution":[1],"Image":[2],"Download":[3],"MS":[4],"PowerPoint":[5],"Slide":[6],"This":[7,95],"report":[8],"describes":[9],"the":[10,24,32,37,71,118,146,153],"development":[11,126],"of":[12,27,36,43,122,145,152],"an":[13],"orally":[14],"active":[15],"analgesic":[16,147],"that":[17,52,69],"resolves":[18],"inflammation":[19,110],"and":[20,57,91,109,114,120,124,148],"neuropathic":[21],"pain":[22],"without":[23],"addictive":[25],"potential":[26],"opioids.":[28],"EC5026":[29,62,123],"acts":[30],"on":[31],"cytochrome":[33],"P450":[34],"branch":[35,151],"arachidonate":[38,154],"cascade":[39],"to":[40,143],"stabilize":[41],"epoxides":[42],"polyunsaturated":[44],"fatty":[45],"acids":[46],"(EpFA),":[47],"which":[48],"are":[49],"natural":[50],"mediators":[51],"reduce":[53],"pain,":[54],"resolve":[55],"inflammation,":[56],"maintain":[58],"normal":[59],"blood":[60],"pressure.":[61],"is":[63],"a":[64],"slow-tight":[65],"binding":[66],"transition-state":[67],"mimic":[68],"inhibits":[70],"soluble":[72],"epoxide":[73],"hydrolase":[74],"(sEH)":[75],"at":[76],"picomolar":[77],"concentrations.":[78],"The":[79],"sEH":[80,86],"rapidly":[81],"degrades":[82],"EpFA;":[83],"thus,":[84],"inhibiting":[85],"increases":[87],"EpFA":[88],"in":[89],"vivo":[90],"confers":[92],"beneficial":[93],"effects.":[94],"mechanism":[96],"addresses":[97],"disease":[98],"states":[99],"by":[100],"shifting":[101],"endoplasmic":[102],"reticulum":[103],"stress":[104],"from":[105],"promoting":[106],"cellular":[107],"senescence":[108],"toward":[111],"cell":[112],"survival":[113],"homeostasis.":[115],"We":[116],"describe":[117],"synthesis":[119],"optimization":[121],"its":[125],"through":[127],"human":[128],"Phase":[129],"1a":[130],"trials":[131],"with":[132],"no":[133],"drug-related":[134],"adverse":[135],"events.":[136],"Additionally,":[137],"we":[138],"outline":[139],"fundamental":[140],"work":[141],"leading":[142],"discovery":[144],"inflammation-resolving":[149],"CYP450":[150],"cascade.":[155]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W3127048941","counts_by_year":[{"year":2026,"cited_by_count":32},{"year":2025,"cited_by_count":37},{"year":2024,"cited_by_count":32},{"year":2023,"cited_by_count":22},{"year":2022,"cited_by_count":30},{"year":2021,"cited_by_count":23},{"year":2020,"cited_by_count":1}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2021-02-15T00:00:00"}
